A surgical system includes a tubular shaft having a wall defining an outer surface and an inner surface disposed about an inner space, the tubular shaft having a proximal end and a distal end. The surgical system also includes at least one light emitter and at least one light sensor disposed at the distal end of the tubular shaft, and one or more leads or conductors electrically coupled to the at least one light emitter or the at least one light sensor. The one or more leads may be disposed in clearances defined by first and second jaws. Alternatively or in addition, the one or more conductors may be formed on a flexible substrate, and the flexible substrate may have a deformed state in which the substrate is disposed in the inner space.

A system for tracking an instrument with ultrasound includes a probe (122) for transmitting and receiving ultrasonic energy and a transducer (130) associated with the probe and configured to move with the probe during use. A medical instrument (102) includes a sensor (120) configured to respond to the ultrasonic energy received from the probe. A control module (124) is stored in memory and configured to interpret the ultrasonic energy received from the probe and the sensor to determine a three dimensional location of the medical instrument and to inject a signal to the probe from the transducer to highlight a position of the sensor in an image.

A sensing device for sensing one or more tissue properties includes an adapter assembly, an actuation assembly, a shuttle, and a piston assembly. The adapter assembly is configured to couple to surgical handheld devices. The actuation assembly extends distally from the adapter assembly and is configured to operably couple to and be engaged by handheld devices coupled thereto. The actuation assembly includes a first drive shaft and a second drive shaft. The shuttle has a clamp and a shuttle sensor, and is coupled to the first drive shaft via a coupling. The shuttle sensor is disposed on the clamp. The piston assembly is coupled to the second drive shaft and configured to compress target tissue between the piston assembly and the clamp of the shuttle.

A modified polyisobutylene-based polymer, method of making, and a medical device that includes such polymer, wherein the modified polyisobutylene-based polymer includes urethane, urea, or urethane-urea groups, hard segments, and soft segments, wherein the soft segments comprise phenoxy-containing polyisobutylene residues, and the hard segments include diisocyanate residues and optionally chain extender residues.

A system includes an endoscope configured for insertion into an internal body cavity and a fluid management system. The fluid management system includes a pump configured to pump fluid through the endoscope into the internal body cavity and a controller configured to determine a pressure within the internal body cavity based upon a current feedback signal received from the pump. A method includes supplying a drive signal to a pump to pump fluid into an internal body cavity, receiving a current feedback signal from the pump, and determining a pressure within the internal body cavity based on the current feedback signal.

A computer system provides patient monitoring and treatment using implanted biosensors. Data associated with a target joint of a patient is collected via one or more implanted biosensors. A plurality of feature values are extracted from the data. The plurality of feature values are processed using a trained classification model to select a recommendation. The recommendation is provided to mitigate hemophilia-related injury to the target joint. Embodiments of the present invention further include a method and program product for providing patient monitoring and treatment using implanted biosensors in substantially the same manner described above.

Disclosed are devices, systems and methods for in vivo monitoring of localized environment conditions within a patient user by measuring analytes, including glucose, oxygen, and/or other analytes. In some aspects, a sensor device includes a wafer-based substrate, at least one electrochemical sensor two-electrode contingent including a working electrode and a reference electrode on the substrate and configured to detect a target analyte in a body fluid when the sensor device is deployed within a subject's body, where the working electrode is functionalized by a chemical layer configured to facilitate a reaction involving the target analyte that produces an electrical signal; and an electronics unit in communication with the electrochemical sensor electrode contingent to transmit the electrical signal to an external processor.

One aspect of the present disclosure relates a method of diagnosis and/or treatment of a solid tumor. The method includes directly measuring neural activity within a solid tumor for a time and determining a state of the solid tumor based on the neural activity. The diagnosis and/or treatment can be determined based on the state of the solid tumor. In some instances, the neural activity can be used in a closed loop to detect the neural activity, determine the state, determine the risk, apply treatment, check again for neural activity, and cease treatment when the neural activity is gone.

A medical treatment system for determining administration of medications to a patient is disclosed. The system uses a plurality of sensors to perform a first set of physiologic measurements in a right side of the heart and a second set of physiologic measurements in a left side of the heart. The system also includes a receiver configured to receive measurement data regarding the first and second sets of physiologic measurements and output to a display device the received measurement data.

Embodiments of the present disclosure relate to heart sound measurements using mobile devices. In an embodiment, a medical system for monitoring heart sounds of a subject comprises a medical device configured to obtain, during a first sampling interval, a first physiological signal. The medical system further comprises a mobile device comprising an accelerator, wherein the accelerator is configured to obtain, during a second sampling interval, a second physiological signal. And, the medical system comprises an analysis component configured to extract heart sounds data from the second physiological signal.